Carbamazepine USP For Compounding (API)

Carbamazepine USP active pharmaceutical ingredient (API) is a synthetic compound used as a medication for the treatment of epileptic seizures and neuropathic pain. It is classified as an anticonvulsant and works by decreasing abnormal electrical activity in the brain. Carbamazepine USP is the pure, unformulated form of the drug that is used in the manufacturing of various dosage forms such as tablets, capsules, and suspensions. It is regulated and standardized by the USP to ensure its quality, purity, and potency in pharmaceutical products.
Carbamazepine USP is a medication that is commonly used for compounding in order to create customized dosage forms for patients. It is a type of anticonvulsant or anti-seizure medication that is primarily used to treat certain types of seizures (partial, generalized tonic-clonic, and mixed), as well as trigeminal neuralgia (a type of chronic pain disorder). It may also be used to treat other conditions such as bipolar disorder and nerve pain. Compounding with carbamazepine allows pharmacists to create dosage forms that are not available commercially, such as suspensions, suppositories, and transdermal gels, to meet the specific needs of individual patients.

CAS Number: 296-46-4